Search
+
    SEARCHED FOR:

    JON FAIREST

    Sanofi launches global health brand, to offer 30 meds on non-profit basis

    The treatments will be provided under the new Impact brand, part of Sanofi's global health unit launched last year, which sits outside the commercial business.

    Sanofi inks pact with Unitaid; to reduce TB drug Rifapentine price by 70%

    In a landmark development, global biopharmaceutical company Sanofi will lower the price of Rifapentine, a critically important drug used to prevent tuberculosis (TB), as part of the agreement with Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria, an official release said on Thursday.

    The Economic Times
    BACK TO TOP